Cart
sales@molnova.com
KNK-437
CAS No. 218924-25-5
KNK-437( KNK437 )
Catalog No. M13492 CAS No. 218924-25-5
An inhibitor of Heat shock protein (HSP) synthesis that dose-dependently inhibits the acquisition of thermotolerance and the induction of various HSPs including HSP105, HSP70, and HSP40 in human colon carcinoma cells.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 47 | In Stock |
|
| 10MG | 67 | In Stock |
|
| 25MG | 145 | In Stock |
|
| 50MG | 263 | In Stock |
|
| 100MG | 494 | In Stock |
|
| 200MG | 680 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameKNK-437
-
NoteResearch use only, not for human use.
-
Brief DescriptionAn inhibitor of Heat shock protein (HSP) synthesis that dose-dependently inhibits the acquisition of thermotolerance and the induction of various HSPs including HSP105, HSP70, and HSP40 in human colon carcinoma cells.
-
DescriptionAn inhibitor of Heat shock protein (HSP) synthesis that dose-dependently inhibits the acquisition of thermotolerance and the induction of various HSPs including HSP105, HSP70, and HSP40 in human colon carcinoma cells; inhibits the acquisition of thermotolerance as developed by sodium arsenite, also inhibited at mRNA levels; shows no antitumor effects and does not increase the thermosensitivity of nontolerant tumors in vivo (up to 200 mg/kg).Colon Cancer Preclinical.
-
In Vitro——
-
In Vivo——
-
SynonymsKNK437
-
PathwayCytoskeleton/Cell Adhesion Molecules
-
TargetHSP
-
RecptorHSP105|HSP40|HSP72
-
Research AreaCancer
-
IndicationColon Cancer
Chemical Information
-
CAS Number218924-25-5
-
Formula Weight245.2307
-
Molecular FormulaC13H11NO4
-
Purity>98% (HPLC)
-
SolubilityDMSO: ≥ 34 mg/mL
-
SMILESO=CN1C(/C(CC1)=C\C2=CC=C(OCO3)C3=C2)=O
-
Chemical Name1-Pyrrolidinecarboxaldehyde, 3-(1,3-benzodioxol-5-ylmethylene)-2-oxo-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Yokota S, et al. Cancer Res. 2000 Jun 1;60(11):2942-8.
2. Koishi M, et al. Clin Cancer Res. 2001 Jan;7(1):215-9.
3. Guo F, et al. Cancer Res. 2005 Nov 15;65(22):10536-44.
molnova catalog
related products
-
Stearic acid
Stearic Acid can reduce metastatic tumor burden. Stearic Acid leads to dramatically reduced visceral fat likely by causing the apoptosis of preadipocytes.
-
AMP-PCP
AMP-PCP is an ATP analogue and can bind to Hsp90 N-terminal domain with a Kd value of 3.8 μM. AMP-PCP binding favors the formation of the active homodimer of Hsp90.
-
KUNG38
A potent, selective Grp94 inhibitor with Kd of 0.44 uM; displays 19-fold selecticity over Hsp90α.
